CATHERINE GAHN, NP
Nurse Practitioner in BATON ROUGE, Louisiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
CATHERINE GAHN, NP filed 2,416 Medicare Part D claims in 2023 as a Nurse Practitioner in BATON ROUGE, Louisiana, prescribing 42% generic.
- 2K
- Part D claims, 2023
- 42%
- generic prescribing
- $264.03
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
CATHERINE GAHN, NP's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
2,416 Top 14% higher than 86% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about CATHERINE GAHN, NP?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Louisiana
How Nurse Practitioner compares to other specialties among Louisiana providers
Nurse Practitioner share within Louisiana
Nurse Practitioner is one of the more visible NUCC categories in Louisiana
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Nurse Practitioner (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Nurse Practitioner ABMS/AOA estimate
Est. board-certified rate (Nurse Practitioner) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Nurse Practitioner US NPIs
Specialty board-certified rate — Nurse Practitioner estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
CATHERINE GAHN, NP appears in the CMS NPPES registry as a Nurse Practitioner provider holding NP credentials at 9001 SUMMA AVE, BATON ROUGE, LA, 70809, with a listed phone of (800) 813-2224. NPI 1588815880 was issued on 10/05/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GAHN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,416 prescription claims written by this provider, covering 471 Medicare beneficiaries and totaling roughly $839K in drug spend, split 58% brand-name and 42% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Nurse Practitioner is a high-volume specialty nationwide, with 87,227 enrolled providers across 56 states and an average of 1,084 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1588815880 |
|---|---|
| Specialty | Nurse Practitioner |
| Credentials | NP |
| Gender | Female |
| NPI Issued | 10/05/2008 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm CATHERINE GAHN, NP's current license status, disciplinary history, and board certifications with the Louisiana State Board of Medical Examiners in Louisiana before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where CATHERINE GAHN, NP bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for CATHERINE GAHN, NP. Source: openpaymentsdata.cms.gov.
Total received
$264
Largest payer
JAZZ PHARMACEUTICALS INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
58% brand-name claims vs 42% generic, on 2,416 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 3,651
- Total Day Supply
- 101,402
- Brand vs Generic
- 58% brand / 42% generic
- Brand Drug Cost
- $792K
- Antibiotic Claims
- 90
Patient Demographics
- Average Patient Age
- 71.8 years
- Avg HCC Risk Score
- 2.05
- Gender Split
- 68% female / 32% male
- Age Distribution
- <65: 87, 65-74: 196, 75-84: 152, 85+: 36
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What CATHERINE GAHN, NP prescribes most
Top Medicare Part D drugs by claim count, 2023
- Albuterol Sulfate …
Albuterol Sulfate Hfa
478 claims
- Trelegy Ellipta
Trelegy Ellipta
260 claims
- Stiolto Respimat 124
Stiolto Respimat
124 claims
- Prednisone 121
Prednisone
121 claims
- Fluticasone-Salmet… 115
Fluticasone-Salmeterol
115 claims
- Montelukast Sodium 100
Montelukast Sodium
100 claims
- Advair Hfa 95
Advair Hfa
95 claims
- Breztri Aerosphere 94
Breztri Aerosphere
94 claims
| Drug | Claims |
|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 478 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 260 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 124 |
| Prednisone | 121 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 115 |
| Montelukast Sodium | 100 |
| Advair Hfa Fluticasone Propion/Salmeterol | 95 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 94 |
| Fluticasone Propionate | 90 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 89 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Nurse Practitioner Overview
How CATHERINE GAHN, NP fits within the Nurse Practitioner landscape nationally.
CATHERINE GAHN, NP's 2,416 claims are above the specialty average of 1,084.
Nearby Nurse Practitioner Providers in Louisiana
Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as GAHN.
Compare Nurse Practitioner nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Louisiana
Frequently Asked Questions
What is CATHERINE GAHN, NP's specialty? ▼
How much does CATHERINE GAHN, NP prescribe under Medicare Part D? ▼
Where is CATHERINE GAHN, NP located? ▼
What is CATHERINE GAHN, NP's NPI number? ▼
Does CATHERINE GAHN, NP prescribe more brand-name or generic drugs? ▼
How many Nurse Practitioner providers are there in the US? ▼
What drugs does CATHERINE GAHN, NP prescribe most often? ▼
Does CATHERINE GAHN, NP accept Medicare? ▼
How can I verify CATHERINE GAHN, NP's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology